Addai-Mensah, Otchere;
Afriyie, Edward Y.;
Sakyi, Samuel Asamoah;
Obirikorang, Christian;
Annani-Akollor, Max Efui;
Owiredu, Eddie-Williams;
Amponsah, Francis A.;
Duneeh, Richard Vikpebah;
Asamoah Adu, Evans
Fetal Rhesus D Genotyping and Sex Determination from Maternal Plasma of Rhesus D-Negative Antenatal Population: The Usefulness of Conventional Polymerase Chain Reaction in Resource-limited Settings
You can manage bookmarks using lists, please log in to your user account for this.
Media type:
E-Article
Title:
Fetal Rhesus D Genotyping and Sex Determination from Maternal Plasma of Rhesus D-Negative Antenatal Population: The Usefulness of Conventional Polymerase Chain Reaction in Resource-limited Settings
Contributor:
Addai-Mensah, Otchere;
Afriyie, Edward Y.;
Sakyi, Samuel Asamoah;
Obirikorang, Christian;
Annani-Akollor, Max Efui;
Owiredu, Eddie-Williams;
Amponsah, Francis A.;
Duneeh, Richard Vikpebah;
Asamoah Adu, Evans
Published:
Hindawi Limited, 2020
Published in:
Obstetrics and Gynecology International, 2020 (2020), Seite 1-6
Description:
Background. This prospective cohort study evaluated the usefulness of conventional PCR in genotyping fetal Rhesus D (RhD) and sex from the maternal plasma of RhD-negative (RhD−) antenatal population in resource-limited settings. Methods. Thirty apparently healthy RhD− pregnant women with RhD positive (RhD+) partners were included. Blood samples were collected from each participant (in the third trimester of pregnancy) for DNA extraction/purification and fetal RhD genotyping. Results. Out of the 30 samples, 26 (86.7%) were found to be RhD+ while 4 (13.3%) were RhD−. The RhD+ comprised 24 (80.0%) RhD+ based on exons 5, 7, and 10 combined. Exons 5 and 7 were detected in two additional samples but not exon 10. Serological phenotyping of neonatal blood confirmed 26 RhD+ and 4 RhD−. There was a perfect agreement between the fetal RhD genotype and neonatal RhD phenotyping after delivery for exons 5 and 7 (concordance = 100%, κ = 100.0%, diagnostic accuracy = 100%, p < 0.0001 ) while exon 10 presented with an almost perfect agreement (concordance = 93.3%, κ = 76.2%, diagnostic accuracy = 93.3%, p < 0.0001 ). Regarding the prenatal test for the SRY gene, 9 (30.0%) were predicted to be males and the remaining 21 (60.0%) were females. All the 9 and 21 anticipated males and females, respectively, were confirmed after delivery (concordance = 100%, κ = 100.0%, diagnostic accuracy = 100%). Conclusion. Our study suggests that conventional PCR using the SRY, RhD exons 5 and 7 could be useful for predicting fetal sex and RhD from maternal peripheral blood in resource-limited settings.